2026 ICD-10-CM Diagnosis Code T50.2X5SAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela

ICD-10-CM CodesS00–T88T36-T50T50

ICD-10-CM T50.2X5S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T50.2X5S is a billable ICD-10-CM diagnosis code for adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T50.2X5S
Billable Status
Yes — Valid for Submission
Code Describes
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
Short Description
Advrs eff of crbnc-anhydr inhibtr, benzo/oth diuretc, sqla
Parent Code
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT50Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances
This CodeT50.2X5SAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T50.2X5S.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)Billing

T50.2X5S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acetazolamide adverse reaction
  • Adverse reaction to chlormerodrin
  • Adverse reaction to mercaptomerin
  • Adverse reaction to mercurophylline
  • Adverse reaction to purine derivative diuretic
  • Adverse reaction to saluretic agent
  • Amiloride adverse reaction
  • Bendroflumethiazide adverse reaction
  • Carbonic anhydrase inhibitor adverse reaction
  • Chlorothiazide adverse reaction
  • Chlorthalidone adverse reaction
  • Cyclopenthiazide adverse reaction
  • Dichlorphenamide adverse reaction
  • Diuretic adverse reaction
  • Hydrochlorothiazide adverse reaction
  • Hydroflumethiazide adverse reaction
  • Hypercalcemia caused by thiazide and/or retinol
  • Mefruside adverse reaction
  • Mercurial diuretic adverse reaction
  • Mersalyl adverse reaction
  • Methyclothiazide adverse reaction
  • Metolazone adverse reaction
  • Osmotic diuretic adverse reaction
  • Polythiazide adverse reaction
  • Potassium sparing diuretic adverse reaction
  • Sulfonamide diuretic adverse reaction
  • Thiazide diuretic adverse reaction
  • Triamterene adverse reaction
  • Xipamide adverse reaction

Coding GuidelinesGuidance

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances (T50). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient No · outpatient Yes

Clinical InformationClinical

  • Acetazolamide

    one of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. it is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. however, its usefulness is transient often because of rapid development of tolerance. its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (from smith and reynard, textbook of pharmacology, 1991, p337)
  • Amiloride

    a pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. this inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. negative potential reduces secretion of potassium and hydrogen ions. amiloride is used in conjunction with diuretics to spare potassium loss. (from gilman et al., goodman and gilman's the pharmacological basis of therapeutics, 9th ed, p705)
  • Bendroflumethiazide

    a thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. it has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (from martindale, the extra pharmacopoeia, 30th ed, p810)
  • Chlormerodrin

    a mercurial compound that has been used as a diuretic but is now superseded by more potent and less toxic drugs. the radiolabeled form has been used as a diagnostic and research tool.
  • Chlorothiazide

    a thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (from martindale, the extra pharmacopoeia, 30th ed, p812)
  • Chlorthalidone

    a benzenesulfonamide-phthalimidine that tautomerizes to a benzophenones form. it is considered a thiazide-like diuretic.
  • Clopamide

    a sulfamoylbenzamide piperidine. it is considered a thiazide-like diuretic.
  • Cyclopenthiazide

    thiazide diuretic also used as an antihypertensive agent.
  • Dichlorphenamide

    a carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
  • Ethoxzolamide

    a carbonic anhydrase inhibitor used as diuretic and in glaucoma. it may cause hypokalemia.
  • Hydrochlorothiazide

    a thiazide diuretic often considered the prototypical member of this class. it reduces the reabsorption of electrolytes from the renal tubules. this results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. it is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
  • Hydroflumethiazide

    a thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (from martindale, the extra pharmacopoeia, 30th ed, p822)
  • Mefruside

    a benzene-sulfonamide-furan. it is used as a diuretic that affects the concentrating ability of the kidney, increases sodium chloride excretion, but may not spare potassium. it inhibits carbonic anhydrases and may increase the blood uric acid level.
  • Mersalyl

    a toxic thiol mercury salt formerly used as a diuretic. it inhibits various biochemical functions, especially in mitochondria, and is used to study those functions.
  • Methazolamide

    a carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
  • Methyclothiazide

    a thiazide diuretic with properties similar to those of hydrochlorothiazide. (from martindale, the extra pharmacopoeia, 30th ed, p825)
  • Metolazone

    a quinazoline-sulfonamide derived diuretic that functions by inhibiting sodium chloride symporters.
  • Polythiazide

    a thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (from martindale, the extra pharmacopoeia, 30th ed, p826)
  • Triamterene

    a pteridinetriamine compound that inhibits sodium reabsorption through sodium channels in renal epithelial cells.
  • Trichlormethiazide

    a thiazide diuretic with properties similar to those of hydrochlorothiazide. (from martindale, the extra pharmacopoeia, 30th ed, p830)
  • Fosfomycin

    an antibiotic produced by streptomyces fradiae.
  • Tromethamine

    an organic amine proton acceptor. it is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. (from merck, 11th ed; martindale, the extra pharmacopoeia, 30th ed, p1424)
  • Xipamide

    a sulfamoylbenzamide analog of clopamide. it is diuretic and saluretic with antihypertensive activity. it is bound to plasma proteins, thus has a delayed onset and prolonged action.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AcetazolamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
AltizideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
AmilorideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
AminometradineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
AmisometradineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
AnhydronT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
BendrofluazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
BendroflumethiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
BenzothiadiazidesT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
BenzthiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
BenzylhydrochlorthiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ButizideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
CardraseT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ChlorazanilT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ChlormerodrinT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ChlorothiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ChlortalidoneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ChlorthalidoneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ClofenamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ClopamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ClorexoloneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
CyclopenthiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
CyclothiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiamoxT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DichlorphenamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiclofenamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Dihydroxypropyl theophyllineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiphyllineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiprophyllineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DisulfamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiucardinT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiupresT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NECT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::benzothiadiazineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::carbonic acid anhydrase inhibitorsT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::furfuryl NECT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::loop (high-ceiling)T50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::mercurial NECT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::osmoticT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::purine NECT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::saluretic NECT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::sulfonamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::thiazide NECT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Diuretic NEC::xanthineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiurginT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
DiurilT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
EpitizideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
EthamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
EthiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
EthoxzolamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
FenquizoneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
FlumethiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
HydrochlorothiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
HydroflumethiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
HydromoxT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MefrusideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MerallurideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MerbaphenT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MercaptomerinT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MercumatilinT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MercuramideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MercurophyllineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MersalylT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MethazolamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MethyclothiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MeticraneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
MetolazoneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Osmotic diureticsT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
PenflutizideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
PolythiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Purine diureticsT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
QuinethazoneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
RegrotonT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ReneseT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Saluretic NECT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
SaluronT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TeclothiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TetrachlormethiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Thiazides (diuretics)T50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ThiomercaptomerinT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ThiomerinT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TiamizideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TriamtereneT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TrichlormethiazideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TripamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TrometamolT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
TromethamineT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
Xanthine diureticsT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
XipamideT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6
ZaroxolynT50.2X1T50.2X2T50.2X3T50.2X4T50.2X5T50.2X6

Patient EducationClinical

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

The full article covers:

  • What is a drug interaction?
  • What are side effects?
  • What are drug allergies?
  • How can I stay safe when taking medicines?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T50.2X5S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.5 Lte efct advrs efct drug
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E944.2 Adv eff acetazolamide
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T50.2X5SOverview

Is T50.2X5S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T50.2X5S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics itself has resolved, not the original event.

What MS-DRG does T50.2X5S group to?

On inpatient claims, adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela maps to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Can T50.2X5S be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

Is T50.2X5S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela on inpatient claims.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.